Ovarialkarzinom: Perioperatives Management

Das Ovarialkarzinom ist das Genitalmalignom mit der höchsten Sterblichkeit. Da charakteristische Frühsymptome fehlen, erfolgt die Diagnose meist in einem fortgeschrittenen Erkrankungsstadium. Die Primärtherapie besteht in einer radikalen Operation mit dem Ziel der makroskopisch kompletten Tumorresektion und einer adjuvanten Chemotherapie mit Carboplatin und Paclitaxel. Der Artikel fasst den aktuellen Stand der Empfehlungen zusammen.

Schlüsselwörter

Ovarialkarzinom - perioperatives Management - ERAS - gynäkologische Onkologie

• Literatur

• 1 Mirza MR, Monk BJ, Herrstedt J. et al. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N Engl J Med 2016; 375: 2154-2164
• 2 Robert Koch-Institut. Bericht zum Krebsgeschehen in Deutschland 2016. Accessed October 20, 2022 at: https://edoc.rki.de/bitstream/handle/176904/3264/28oaKVmif0wDk.pdf?sequence=1&isAllowed=y
• 3 Heintz AP, Odicino F, Maisonneuve P. et al. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006; 95 (Suppl. 01) S161-S192
• 4 Bray F, Ferlay J, Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424
• 5 Trimbos B, Timmers P, Pecorelli S. et al. Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Natl Cancer Inst 2010; 102: 982-987
• 6 du Bois A, Reuss A, Pujade-Lauraine E. et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer 2009; 115: 1234-1244
• 7 Harter P, Sehouli J, Lorusso D. et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 2019; 380: 822-832
• 8 Fotopoulou C, Planchamp F, Aytulu T. et al. European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery. Int J Gynecol Cancer 2021; 31: 1199-1206
• 9 Nelson G, Bakkum-Gamez J, Kalogera E. et al. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer 2019; 29: 651-668
• 10 Oskay-Ozcelik G, Alavi S, Richter R. et al. Expression III: patients’ expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries. Ann Oncol 2018; 29: 910-916
• 11 Havrilesky LJ, Yang JC, Lee PS. et al. Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer. Cancer 2019; 125: 4399-4406
• 12 Schneider S, Armbrust R, Spies C. et al. Prehabilitation programs and ERAS protocols in gynecological oncology: a comprehensive review. Arch Gynecol Obstet 2020; 301: 315-326
• 13 Bretagnol F, Panis Y, Rullier E. et al. Rectal cancer surgery with or without bowel preparation: the French GRECCAR III multicenter single-blinded randomized trial. Ann Surg 2010; 252: 863-868
• 14 Cao F, Li J, Li F. Mechanical bowel preparation for elective colorectal surgery: updated systematic review and meta-analysis. Int J Colorectal Dis 2012; 27: 803-810
• 15 Rollins KE. Bowel preparation in elective colorectal surgery: is mechanical bowel preparation necessary?. Lancet Gastroenterol Hepatol 2020; 5: 712-713
• 16 Migaly J, Bafford AC, Francone TD. et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the use of bowel preparation in elective colon and rectal surgery. Dis Colon Rectum 2019; 62: 3-8
• 17 Ban KA, Minei JP, Laronga C. et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg 2017; 224: 59-74
• 18 Sehouli J, Mueller K, Richter R. et al. Effects of sarcopenia and malnutrition on morbidity and mortality in gynecologic cancer surgery: results of a prospective study. J Cachexia Sarcopenia Muscle 2021; 12: 393-402
• 19 Inci MG, Anders L, Woopen H. et al. Frailty Index for prediction of surgical outcome in ovarian cancer: results of a prospective study. Gynecol Oncol 2021; 161: 396-401
• 20 Sehouli J, Heise K, Richter R. et al. Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study. Arch Gynecol Obstet 2021; 303: 1057-1063
• 21 Plett H, Ricciardi E, Bommert M. et al. Current practice and physicians’ opinion about preoperative hair removal as a part of ERAS pathway implementation in gynecology and gynecology-oncology: a NOGGO-AGO survey of 148 gynecological departments in Germany. Arch Gynecol Obstet 2019; 299: 1607-1618
• 22 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG) (federführend). Empfehlungen zur Verhinderung lagerungsbedingter Schäden in der operativen Gynäkologie. Accessed October 20, 2022 at: https://www.awmf.org/leitlinien/detail/ll/015–077.html
• 23 Bommert M, Wagner JK, Sehouli J. et al. Perioperative management of positioning in gynecological cancersurgery: a national NOGGO-AGO intergroup survey. Int J Gynecol Cancer 2020; 30: 1589-1594
• 24 Hunsicker O, Gericke S, Graw JA. et al. Transfusion of red blood cells does not impact progression-free and overall survival after surgery for ovarian cancer. Transfusion 2019; 59: 3589-3600
• 25 AWMF. S3-Leitlinie Diagnostik und Therapie der Präoperativen Anämie. AWMF Registernummer 001–0024 (in Überarbeitung). Accessed October 20, 2022 at: https://www.awmf.org/leitlinien/detail/ll/001–024.html
• 26 Hunsicker O, Fotopoulou C, Pietzner K. et al. Hemodynamic consequences of malignant ascites in epithelial ovarian cancer surgery*: a prospective substudy of a randomized controlled trial. Medicine (Baltimore) 2015; 94: e2108
• 27 Feldheiser A, Pavlova V, Bonomo T. et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth 2013; 110: 231-240
• 28 Kaufner L, Niggemann P, Baum T. et al. Impact of brief prewarming on anesthesia-related core-temperature drop, hemodynamics, microperfusion and postoperative ventilation in cytoreductive surgery of ovarian cancer: a randomized trial. BMC Anesthesiol 2019; 19: 161
• 29 Bergqvist D, Agnelli G, Cohen AT. et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346: 975-980
• 30 Rasmussen MS, Jorgensen LN, Wille-Jorgensen P. et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost 2006; 4: 2384-2390
• 31 Guntupalli SR, Brennecke A, Behbakht K. et al. Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial. JAMA Netw Open 2020; 3: e207410
• 32 Bisch S, Nelson G, Altman A. Impact of nutrition on enhanced recovery after surgery (ERAS) in Gynecologic Oncology. Nutrients 2019; 11: 1088